Feature Channels: Diabetes

Filters close
Released: 6-Apr-2020 5:10 PM EDT
Researchers Identify Potential Early Biomarker to Track Development of Dangerous Non-alcoholic Fatty Liver Disease
Joslin Diabetes Center

Fatty liver disease not associated with alcohol consumption, which is called Nonalcoholic Fatty Liver Disease or NAFLD, affects more than one billion people worldwide. Even in children the numbers are overwhelming, with up to 80 percent of pediatric patients who are considered obese affected worldwide. People with NAFLD can progress to a severe form known as nonalcoholic steatohepatitis (NASH), which puts patients at higher risk for cirrhosis or liver cancer.

Released: 6-Apr-2020 12:05 PM EDT
Joslin Research Ties Autoimmunity-Associated Heart Dilation to Potential Heart-Failure Risk in Type 1 Diabetes
Joslin Diabetes Center

There's a higher case fatality rate in type 1 than type 2 diabetes, which suggests different mechanisms for heart failure might be involved in type 1 diabetes.” Given the burden of heart failure in type 1 diabetes, the early identification of patients at particular risk is of importance.

Released: 6-Apr-2020 11:55 AM EDT
Brown Fat Can Burn Energy in an Unexpected Way
Joslin Diabetes Center

Joslin researchers have found a pathway that can boost the production of (heat-generating, fat-burning) brown fat cells without also creating unhelpful white fat cells. This finding suggests that the pathway the Joslin team uncovered might offer a solution to that challenge.

Released: 2-Apr-2020 1:10 PM EDT
Medical teams need to be alert to the extra risks faced by diabetics from COVID-19
University of Leeds

Doctors need to pay particular attention to patients with endocrine disorders and diabetes mellitus in relation to COVID-19 infections, say leading endocrinologists.

Newswise: Fatty acid in triglycerides proves an effective platform for biological drug delivery
Released: 2-Apr-2020 8:30 AM EDT
Fatty acid in triglycerides proves an effective platform for biological drug delivery
Houston Methodist

Houston Methodist nanomedicine researchers are studying a new drug delivery system that transports oral medication via triglycerides that could eliminate the need for injections or IV treatments of some biologic drugs for rheumatoid arthritis and other autoimmune diseases. They’re doing this with a diabetes drug that resulted in approximately 25% absorption in mice models, considered very high for an oral drug. The research will appear in Science Advances April 1.

Released: 31-Mar-2020 12:10 PM EDT
AADE7 Self-Care Behaviors revised in new guidance from the Association of Diabetes Care & Education Specialists
Association of Diabetes Care & Education Specialists (ADCES)

The framework for the AADE7 Self-Care Behaviors were recently published, highlighting changes in diabetes care and management.

Released: 31-Mar-2020 12:00 PM EDT
Individuals taking class of steroid medications at high risk for COVID-19
Endocrine Society

Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according to a new editorial published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

25-Mar-2020 12:40 PM EDT
Coconut oil reduces features of metabolic syndrome in obese females, animal study finds
Endocrine Society

Obese females that ate a small amount of coconut oil daily, even as part of a high-fat diet, had decreased features of metabolic syndrome, a cluster of risk factors that raise the chances of developing diabetes, heart disease and stroke, an animal study finds. The study results were accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be published in a special supplemental section of the Journal of the Endocrine Society.

25-Mar-2020 9:00 AM EDT
Technology use by adults with type 1 diabetes lower among African Americans, Hispanics
Endocrine Society

Continuous glucose monitor (CGM) and continuous subcutaneous insulin infusion (CSII) devices are known to improve outcomes in patients with type 1 diabetes (T1D), yet African American and Hispanic patients face barriers to the use of these devices, according to results of a small single-center retrospective study. The results of the ENDO 2020 abstract will be published in the Journal of the Endocrine Society.

26-Mar-2020 11:45 AM EDT
Two types of diabetes drugs similarly effective in reducing heart and kidney disease
Endocrine Society

Two newer types of medications commonly used to treat type 2 diabetes are similar in their ability to reduce major heart complications, including heart attack, stroke and death from cardiovascular disease, according to research accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.


Showing results

110 of 10

close
1.32488